BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/16/2025 10:38:20 AM | Browse: 142 | Download: 701
 |
Received |
|
2024-12-31 02:56 |
|
Peer-Review Started |
|
2024-12-31 02:56 |
|
First Decision by Editorial Office Director |
|
2025-03-05 07:55 |
|
Return for Revision |
|
2025-03-05 07:55 |
|
Revised |
|
2025-03-09 15:45 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-03-13 02:35 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-03-13 09:19 |
|
Articles in Press |
|
2025-03-13 09:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-04-30 09:43 |
|
Publish the Manuscript Online |
|
2025-06-16 10:38 |
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Prospective Study |
| Article Title |
Anti-vaccine antibodies against measles, rubella, parotitis and hepatitis B in children with inflammatory bowel disease and healthy controls
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Elizaveta Makarova, Olga Goleva, Tatiana Gabrusskaya, Natalia Ulanova, Natalia Volkova, Elena Shilova, Maria Tolkmit, Maria Revnova, Susanna Kharit and Mikhail Kostik |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mikhail Kostik, MD, PhD, Professor, Hospital Pediatry, Saint-Petersburg State Pediatric Medical University, Lytovskaya 2, Saint-Petersburg 194100, Russia. kost-mikhail@yandex.ru |
| Key Words |
Inflammatory bowel diseases; Vaccine; Measles; Mumps; Rubella; Hepatitis B; Antibodies; Anti-vaccine antibodies; Vaccine coverage; Children |
| Core Tip |
Improving vaccination, engaging the trust of parents and physicians in vaccination, and its safety and efficacy in children with immune-mediated diseases could decrease the infection risks. This study showed the vaccine coverage, the predictors of incomplete vaccination, and non-protective levels of post-vaccine antibodies. The younger onset of the disease onset disrupts the following scheduled vaccination. Avoiding corticosteroid treatment, regular assessment of anti-vaccine antibodies, and encouragement of vaccination are the main goals for managing patients with inflammatory bowel diseases. |
| Publish Date |
2025-06-16 10:38 |
| Citation |
Makarova E, Goleva O, Gabrusskaya T, Ulanova N, Volkova N, Shilova E, Tolkmit M, Revnova M, Kharit S, Kostik M. Anti-vaccine antibodies against measles, rubella, parotitis and hepatitis B in children with inflammatory bowel disease and healthy controls. World J Clin Pediatr 2025; 14(3): 104704 |
| URL |
https://www.wjgnet.com/2219-2808/full/v14/i3/104704.htm |
| DOI |
https://dx.doi.org/10.5409/wjcp.v14.i3.104704 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
